хочу придумать терапию для улучшения функционального состояния кожи людей среднего возраста до состояния молодых людей

Why might repeated skin treatment speed up dangerous cell growth?

The question as the research states itCan repeated removal leave skin clearer but accelerate dangerous surviving cells, and can preserving neighbors prevent that growth?

The whole reason

If that sequence occurs, clearer-looking skin could conceal worsening underlying risk. If preserved neighbors prevent the acceleration, their retention would change the consequences of removal, but their mere presence cannot be assumed to provide protection.

The question in full

The question concerns whether repeatedly removing altered skin cells could allow dangerous surviving cell families to grow faster, even while visible patches of abnormal skin disappear. These cell families are called clones because their cells descend from a shared original cell. It asks whether keeping neighboring cells that compete with the survivors prevents this acceleration, compared with removal that does not preserve those neighbors. The pipeline assumes that a treatment called RL-3 clears active lesions, while competition and deeper surviving cells make that clearance an uncertain sign of lasting benefit. The intended outcome is controlled clone growth over ten years and detection of dangerous lesions before lasting damage, but the supplied material defines neither acceptable growth nor how danger is measured.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

01Repeated treatment may spare dangerous cell lineages and free them from competitionRepeated treatment could favor dangerous, death-resistant cell lineages and allow growth by removing competitors. The model would be insufficient if transferred cell-death products determine growth despite matched surviving lineages and competitors.
02Signals from dying cells may drive altered skin cell growth through prostaglandin E2Caspase-3 in dying cells may trigger prostaglandin E2 production, repeatedly stimulating surviving altered keratinocytes without new inherited changes. Blocking production and restoring the measured concentration would test this; persistent acceleration after prolonged mediator removal would argue against it.

Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe

Измеренные до опыта вероятности выживания каждой линии должны предсказывать её обогащение сразу после каждого удаления. При одинаковой общей гибели режим, сильнее сохраняющий опасные линии, даст большее их обогащение. После этого сохранение либо восстановление живых конкурентов должно уменьшить абсолютный межцикловой прирост опасных линий при сопоставимых продуктах гибели. Для объяснения результата не потребуются новые донорские последовательности. Если рост определяется составом перенесённых продуктов гибели при одинаковых выживших линиях и конкурентах, данная модель будет недостаточной. Hypothetical result

Would support the hypothesis

Repeated treatment may spare dangerous cell lineages and free them from competition — Repeated treatment could favor dangerous, death-resistant cell lineages and allow growth by removing competitors. The model would be insufficient if transferred cell-death products determine growth despite matched surviving lineages and competitors.

Other hypotheses predict

Signals from dying cells may drive altered skin cell growth through prostaglandin E2 — При одинаковых выживших линиях, количестве конкурентов и исходной гибели перенос бесклеточной среды, освобождённой от ДНК и клеточных частиц, должен воспроизводить ускорение роста. Подавление образования простагландина E2 в погибающих клетках должно устранять эффект, а возвращение измеренной концентрации медиатора должно его восстанавливать. После прекращения таких импульсов дополнительная скорость роста должна снижаться. Устойчивое ускорение после длительного удаления медиатора, особенно связанное с новым наследуемым генотипом, будет аргументом против этой гипотезы.

What to check next

Does repeated removal of altered skin cells accelerate surviving clones despite visible lesion clearance, and does preserving competing neighbors prevent that acceleration?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

Repeated treatment may spare dangerous cell lineages and free them from competition

Selective survival and competitive release

Proposed mechanism

Repeated treatment could favor dangerous, death-resistant cell lineages and allow growth by removing competitors.

Full text

Повторная терапия преимущественно сохраняет заранее существующие опасные линии, устойчивость которых связана с подавлением гибели клеток. Одновременно она удаляет клетки, ограничивающие их размножение. Наследуемый состав выжившей популяции последовательно меняется, а уменьшение конкуренции позволяет устойчивым линиям увеличивать абсолютную численность между циклами. Сохранение жизнеспособных конкурентов должно предотвращать ускорение даже при той же доле первоначально уничтоженных изменённых клеток. Поддержание такого ограничения роста должно стабилизировать SPV_10.

What distinguishes its prediction

Измеренные до опыта вероятности выживания каждой линии должны предсказывать её обогащение сразу после каждого удаления.

Full text

При одинаковой общей гибели режим, сильнее сохраняющий опасные линии, даст большее их обогащение. После этого сохранение либо восстановление живых конкурентов должно уменьшить абсолютный межцикловой прирост опасных линий при сопоставимых продуктах гибели. Для объяснения результата не потребуются новые донорские последовательности. Если рост определяется составом перенесённых продуктов гибели при одинаковых выживших линиях и конкурентах, данная модель будет недостаточной.

What would weaken the hypothesis

В мозаичной модели кожи погибающие клоны получают разные нейтральные генетические метки рядом с исследуемыми аллелями, а реципиенты имеют независимую метку происхождения.

Full text

После повторных циклов ускоренно растущие потомки реципиентов должны содержать устойчиво наследуемые донорские фрагменты с подтверждёнными местами интеграции. Удаление ДНК из выделенной фракции продуктов гибели должно устранять ускорение при сохранении её липидного состава; возвращение интактного материала должно восстанавливать эффект. Отсутствие интеграции при достаточной чувствительности и сохранение ускорения после удаления донорской ДНК опровергнут гипотезу в пользу отбора либо растворимого ростового стимула.

Signals from dying cells may drive altered skin cell growth through prostaglandin E2 predicts instead: При одинаковых выживших линиях, количестве конкурентов и исходной гибели перенос бесклеточной среды, освобождённой от ДНК и клеточных частиц, должен воспроизводить ускорение роста. Подавление образования простагландина E2 в погибающих клетках должно устранять эффект, а возвращение измеренной концентрации медиатора должно его восстанавливать. После прекращения таких импульсов дополнительная скорость роста должна снижаться. Устойчивое ускорение после длительного удаления медиатора, особенно связанное с новым наследуемым генотипом, будет аргументом против этой гипотезы.

Signals from dying cells may drive altered skin cell growth through prostaglandin E2

Death associated paracrine biochemistry

Proposed mechanism

Caspase-3 in dying cells may trigger prostaglandin E2 production, repeatedly stimulating surviving altered keratinocytes without new inherited changes.

Full text

Главным источником ускорения становится биохимический импульс, возникающий при гибели удаляемых клеток. Каспаза-3 запускает образование простагландина E2, который усиливает размножение выживших изменённых кератиноцитов. Каждый следующий цикл повторяет этот стимул, поэтому абсолютный рост может ускоряться без приобретения новых наследственных изменений. Сохранение конкурентов обеспечивает лишь частичную защиту, если продукция простагландина остаётся высокой. Разделение уничтожения изменённых клеток и образования ростового медиатора должно стабилизировать SPV_10.

What distinguishes its prediction

При одинаковых выживших линиях, количестве конкурентов и исходной гибели перенос бесклеточной среды, освобождённой от ДНК и клеточных частиц, должен воспроизводить ускорение роста.

Full text

Подавление образования простагландина E2 в погибающих клетках должно устранять эффект, а возвращение измеренной концентрации медиатора должно его восстанавливать. После прекращения таких импульсов дополнительная скорость роста должна снижаться. Устойчивое ускорение после длительного удаления медиатора, особенно связанное с новым наследуемым генотипом, будет аргументом против этой гипотезы.

What would weaken the hypothesis

Full text

Repeated treatment may spare dangerous cell lineages and free them from competition predicts instead: Измеренные до опыта вероятности выживания каждой линии должны предсказывать её обогащение сразу после каждого удаления. При одинаковой общей гибели режим, сильнее сохраняющий опасные линии, даст большее их обогащение. После этого сохранение либо восстановление живых конкурентов должно уменьшить абсолютный межцикловой прирост опасных линий при сопоставимых продуктах гибели. Для объяснения результата не потребуются новые донорские последовательности. Если рост определяется составом перенесённых продуктов гибели при одинаковых выживших линиях и конкурентах, данная модель будет недостаточной.

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: Does repeated removal of altered skin cells accelerate surviving clones despite visible lesion clearance, and does preserving competing neighbors prevent that acceleration?

Every proposed test

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Can repeated removal leave skin clearer but accelerate dangerous surviving cells, and can preserving neighbors prevent that growth?

What this question is asking

What the terms mean

Altered or mutant cell: An altered cell differs from the reference cell state; a mutant cell specifically carries a genetic change. These labels do not by themselves establish that a cell is dangerous.
Clone: A family of cells descended from one original cell. Clone expansion means that this family increases in size or occupies more tissue.
Lesion: A localized patch of abnormal tissue. Its visible disappearance measures clearance of that patch, not necessarily elimination of every altered cell.
RL-3: The pipeline's label for the proposed skin treatment. The supplied material provides no expansion of the label or description of its components or method.
Cell competition and competitive release: Cell competition describes how neighboring cell populations influence which cells persist or expand. Competitive release is the proposed reduction of that restraint after competitors are removed; its occurrence after the treatment in this question remains unestablished.
Deep surviving reserves: The pipeline's proposed cells deeper in the skin that remain after surface lesions clear. Their location, identity and survival after treatment are not established by the supplied sources.
Epidermis: The outer layer of skin. The epidermis between hair follicles is the part of that layer outside the structures from which hairs grow.
Stem cell: A cell capable of maintaining its population while supplying cells to a tissue. Its persistence and descendants' expansion are the outcomes discussed in S2 and S4.
Deoxyribonucleic acid: The molecule that carries genetic information. S2 concerns cells with damage that breaks both strands of this molecule.
p53 mutation: A genetic change affecting p53, a protein involved in controlling cell responses to damage. The supplied findings concern particular p53-mutant cell populations and do not establish that every such mutation has the same consequences.
Logistic growth curve: A growth pattern in which expansion slows as the growing population approaches a limit. S6 uses this pattern to describe the approximate growth of the studied mutant clones.
Crowding feedback and tissue homeostasis: Crowding feedback means that local cell density changes how cells behave. Tissue homeostasis means maintaining stable tissue organization through ongoing cell activity; S6 links this stability to responses to crowding.
Simulation: A model that calculates how a system behaves under specified rules. S6's modeled results do not themselves establish what repeated treatment does in human skin.
Selective growth advantage: A relative advantage that allows one cell population to expand more successfully than others in a particular setting. It depends on context and does not itself measure damage to the organism.
Rheumatoid arthritis synovium: Joint-lining tissue affected by rheumatoid arthritis, an inflammatory disease. This is the tissue setting of S7, rather than skin.

What the question takes for granted

Premise only partly supported

RL-3 removes active lesions, but release from cellular competition and deep surviving reserves limit what visible clearance establishes about long-term risk.

RL-3 is the treatment label supplied by the pipeline, and lesions are patches of abnormal skin that it is said to remove. The assumption is that cells remaining nearby or deeper in the skin can behave differently after removal changes their surroundings. If true, disappearance of visible patches would leave unanswered whether dangerous cell families are still expanding.

S4 supports the narrower claim that spatial surroundings and cell competition influence the fate of altered skin stem cells. S6 reports a role for responses to crowding in maintaining stable tissue organization in simulations. Neither establishes that RL-3 clears lesions, that deep reserves survive it, or that repeated clearance releases dangerous survivors from competition. The supplied sources therefore support part of the ecological rationale, while leaving the treatment-specific assertions unestablished.S4 S6

The same question asked without the part nothing read establishes:

Does repeated removal of altered skin cells accelerate surviving clones despite visible lesion clearance, and does preserving competing neighbors prevent that acceleration?
How does preserving neighboring cells change surviving clone growth after repeated removal of altered skin cells?

What turns on the answer

Removal accelerates survivors; preserved neighbors prevent it Under the proposed mechanism, removal reduces competition and surviving dangerous clones expand faster despite visible clearance. If preserving neighbors blocks that acceleration, the cellular surroundings would determine whether clearance carries this hidden cost.
Removal accelerates survivors; preserved neighbors do not prevent it Dangerous survivors would expand faster after removal even when neighboring competitors remain. Visible clearance and neighbor preservation would then both be insufficient to establish control of the surviving clones.
Removal does not accelerate dangerous survivors Repeated removal would not produce the particular competitive-release effect posed by the question. That outcome alone would still not establish ten-year control or detection before lasting damage, because those are separate outcomes.

Why it matters

Visible lesion clearance and the subsequent growth of surviving cells are different outcomes. The proposed concern is that removing cells reduces competition, which could give dangerous survivors more room to expand; the supplied sources do not establish this sequence after repeated treatment. If that sequence occurs, clearer-looking skin could conceal worsening underlying risk. If preserved neighbors prevent the acceleration, their retention would change the consequences of removal, but their mere presence cannot be assumed to provide protection.

Still open

None of the read sources settles either repeated-removal acceleration or its prevention by preserved neighbors. The nearest work establishes spatial competition in human skin (S4), expansion of intact neighbors during selective damaged-cell elimination (S2), and crowding-dependent behavior in simulations (S6). S5 also shows mutant expansion despite ordinary neighbors; S7 concerns a different tissue and disease setting. The inference from these findings is that cellular surroundings can matter, not that the proposed treatment effect occurs. This verdict describes the supplied evidence, not proof that no answer exists elsewhere.S4 S2 S6 S5 S7

What the literature establishes

The abstract of S2 reports that selective elimination of cells with breaks across both strands of deoxyribonucleic acid was coupled with increased expansion of intact neighboring stem-cell clones. This describes expansion of intact cells, not dangerous treatment survivors.S2
S4 reports that spatial context and cell competition jointly determine the fate of a mutant stem cell in human epidermis.S4
In the mouse skin model described by S5, cells carrying a p53 mutation became dominant over neighboring cells without that mutation and colonized the epidermis between hair follicles.S5
S6 reports that growth of p53-mutant clones in mouse epidermis approximates a logistic curve and that feedback responding to local crowding is required to maintain tissue homeostasis in its simulations.S6
S7 reports that some mutant clones acquire a selective growth advantage in the process it examines. Its setting is rheumatoid arthritis synovium, so this is background evidence rather than a finding about repeated skin-cell removal.S7

What it does not settle

Whether repeated removal accelerates dangerous surviving skin clones, including when visible lesions disappear.
Whether preserving competing neighbors prevents any removal-induced acceleration. Evidence that competition affects clone fate does not establish this protective effect.S4 S5
What RL-3 consists of, whether it clears active lesions, and whether deeper surviving cell reserves affect its outcomes.
Whether outcomes persist over ten years in middle-aged human skin, how large any effect is, and whether dangerous lesions are detected before lasting damage.
Which altered clones qualify as dangerous and what growth limits would count as acceptable. Mutation or expansion alone is not identified as a sufficient danger criterion in the supplied material.

Where the sources disagree

S5 challenges any blanket assumption that retaining ordinary neighboring cells necessarily restrains mutant clones: mutant cells became dominant and colonized tissue despite such neighbors. This does not directly refute protection after repeated removal, which S5 did not study, or contradict S4's broader finding that competition influences clone fate.S5 S4

Sources read · 5

4 literature searches, 7 full texts, 2 abstract-only; 9 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S2BackgroundAbstract only

Dynamic stem cell selection safeguards the genomic integrity of the epidermis. · Developmental cell · 2021

“Moreover, concomitant enhancement of symmetric cell divisions of surrounding stem cells indicates that the selective elimination of cells with DSBs is coupled with the augmented clonal expansion of intact stem cells.”

Does not settle: В абстракте не рассматриваются повторные удаления клеток, рост опасных выживших клонов после исчезновения очагов или предотвращение такого роста сохранением конкурирующих клеточных соседей.

S4Partly answers it

Spatial constraints govern competition of mutant clones in human epidermis. · Nature communications · 2017

“These findings demonstrate that spatial context and cell competition cooperate to determine the fate of a mutant stem cell.”

Does not settle: Источник не устанавливает, ускоряет ли повторное удаление изменённых клеток рост опасных выживших клонов, исчезают ли при этом очаги и предотвращает ли сохранение конкурирующих клеточных соседей такой эффект.

S5Contradicts it

Epidermal Tissue Adapts to Restrain Progenitors Carrying Clonal p53 Mutations. · Cell stem cell · 2018

“We concluded that following induction p53 ∗/wt cells are dominant over wild-type keratinocytes, leading to colonization of the IFE.”

Does not settle: Источник не изучает повторное удаление изменённых клеток, исчезновение очагов или опасность выживших клонов. Он также не устанавливает, предотвращают ли конкурирующие соседние клетки рост клона: в модели мышиного эпидермиса мутантные клетки колонизировали ткань среди клеток дикого типа.

S6Background

Simulations reveal that different responses to cell crowding determine the expansion of p53 and Notch mutant clones in squamous epithelia. · Journal of the Royal Society, Interface · 2021

“p53 mutant clone growth in mouse epidermis approximates a logistic curve, but feedbacks responding to local crowding are required to maintain tissue homeostasis.”

Does not settle: Источник не изучает повторное удаление изменённых клеток, ускорение роста выживших опасных клонов после такого удаления или предотвращение этого эффекта сохранением конкурирующих клеточных соседей.

S7Background

Regional analysis of p53 mutations in rheumatoid arthritis synovium. · Proceedings of the National Academy of Sciences of the United States of America · 2002

“This process, as in sun-exposed skin and inflamed colonic epithelium, provides some of the mutant clones with a selective growth advantage.”

Does not settle: Источник оставляет открытыми последствия повторного удаления изменённых клеток, ускорение роста выживших опасных клонов и защитную роль сохранённых конкурирующих клеточных соседей.

Every open question